Morgan Stanley
-
BOC Aviation is set to raise at least HK$8.7bn ($1.1bn) from its Hong Kong IPO, as it looks to kick off bookbuilding next Monday with a fixed price.
-
Kallpa Generación, the Peruvian power generation company, will begin investor meetings today ahead of a potential debut dollar bond in what would be the first non-sovereign Peruvian new issue of 2016.
-
Kraft Heinz Foods printed a €1.8bn two tranche note with minimal concessions on Wednesday — a day that produced more than €7bn of primary issuance and proved that investors were hungry for variety in the sectors they buy.
-
A successful listing of state-owned Hidroelectrica could serve as a catalyst for further sales of state-owned assets in Romania, investors believe.
-
CDH is in the market to cash out of its stake in Luye Pharma Group via a block trade worth up to HK$729m ($94m).
-
Chinese names are continuing their resurgence with State Grid Corp of China returning for a dollar/euro combo while China International Capital Corp (Hong Kong) has opened books for its debut offshore appearance.
-
Agricultural Bank of China New York raised $1.25bn from a dual-tranche offering on Monday, hitting the market early given expectations of more supply over the week. The issuer sealed a bigger floating rate note as it provides protection against volatility induced by the Federal Reserve, but executed the trade in an unusual manner.
-
Oil company Shell printed a €1.75bn bond on Monday as it joined another three issuers printing almost €6bn of bonds in the European corporate investment grade market.
-
Biopharmaceutical company AstraZeneca hit a frenzied corporate bond market on Monday with a €2.2bn three tranche bond that contributed to around €6bn of primary supply that day.
-
Agricultural Bank of China New York has returned to the offshore bond market, having started bookbuilding for a dual-tranche dollar transaction on Monday morning.
-
ICBC Financial Leasing is on the road to meet investors ahead of plans to sell its first dollar bond of the year.
-
Samsung Biologics, which sent out a request for proposals for its South Korean IPO on April 29, is understood to have invited nine domestic and six international firms to submit bids.